StimLabs

Here's to a joyous, healthy, and fulfilling 2025! #stimlabs #HappyNewYear

StimLabs is adding select distributor partners to expand our product portfolio within the U.S. hospital operating room market!   If you have a well-established hospital operating room network and are passionate about bringing innovative technology to patients in need, contact us to learn more about available distribution opportunities at https://bit.ly/3BRegHh   #DistributorPartners #HospitalBusiness #StimLabs #HealthcareInnovation 

StimLabs hopes everyone has a cheerful holiday season filled with peace, prosperity, and joy! #stimlabs #happyholidays

We love to celebrate the hard work and dedication of our team members and partners. This week, we were thrilled to host Christie Blakely, MBA from our new strategic partner, Geistlich. Together, we discussed the exciting plans for the U.S. launch of Derma-Gide® in 2025, marking a significant milestone for our organizations.   We also celebrated the holiday season with a heartwarming lunch for the entire StimLabs team! What a great way to end another successful season. #happyholidays #stimlabs #geistlich

In this post-Mohs case report, Cogenex allografts were selected as a wound covering since a complex repair was not appropriate due to the location of the defect and the desire to preserve normal anatomy. Read more at https://bit.ly/3OS0EhT #stimlabs #cogenex #mohsmicrographicsurgery

At StimLabs, we’re grounded in values that inspire innovation, compassion, and excellence. Learn more about our mission, vision, and purpose that shape our approach and guide our work. https://bit.ly/3CVg4zr

As we celebrate Thanksgiving, we’d like to recognize the contributions and commitment of our team and our clinicians. Your hard work and passion are the driving forces behind the positive change we bring to the lives we touch. We are thankful for each of you. #thanksgiving #stimlabs

We're pleased to announce that StimLabs has entered into an exclusive national distribution agreement with Geistlich to commercialize an innovative wound care product line - beginning with Derma-Gide®. Derma-Gide is a porcine-derived advanced wound matrix and is covered under the Future Effective Skin Substitute LCDs for DFUs (Q4203). We are excited about this partnership between two companies with shared values of innovation excellence and supporting better patient outcomes. Read the press release here: https://bit.ly/3AOgcA1 Geistlich Pharma #StimLabs #WoundCare #Geistlich #DermaGide

The annual StimLabs Tailgate Cookout was a fantastic opportunity for our team to come together, share some laughs, and enjoy great food—especially with our executives taking over the grills! We appreciate the leadership and effort that went into making this event a success, and we look forward to many more moments like this. #stimlabs

Corplex P’s complex scaffold is comprised of a diverse array of human ECM components. #corplexp #stimlabs #umbilicalcord